- Home
- HOWL vs ANIX Comparison
HOWL vs ANIX Comparison
Compare HOWL & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOWL
- ANIX
- Stock Information
- Founded
- HOWL 2017
- ANIX 1982
- Country
- HOWL United States
- ANIX United States
- Employees
- HOWL N/A
- ANIX N/A
- Industry
- HOWL Biotechnology: Pharmaceutical Preparations
- ANIX Biotechnology: Pharmaceutical Preparations
- Sector
- HOWL Health Care
- ANIX Health Care
- Exchange
- HOWL Nasdaq
- ANIX Nasdaq
- Market Cap
- HOWL 53.4M
- ANIX 108.9M
- IPO Year
- HOWL 2021
- ANIX 1987
- Fundamental
- Price
- HOWL $1.07
- ANIX $3.23
- Analyst Decision
- HOWL Strong Buy
- ANIX Strong Buy
- Analyst Count
- HOWL 3
- ANIX 3
- Target Price
- HOWL $8.33
- ANIX $9.00
- AVG Volume (30 Days)
- HOWL 612.4K
- ANIX 242.9K
- Earning Date
- HOWL 08-07-2025
- ANIX 05-28-2025
- Dividend Yield
- HOWL N/A
- ANIX N/A
- EPS Growth
- HOWL N/A
- ANIX N/A
- EPS
- HOWL N/A
- ANIX N/A
- Revenue
- HOWL $1,143,000.00
- ANIX N/A
- Revenue This Year
- HOWL N/A
- ANIX N/A
- Revenue Next Year
- HOWL N/A
- ANIX N/A
- P/E Ratio
- HOWL N/A
- ANIX N/A
- Revenue Growth
- HOWL N/A
- ANIX N/A
- 52 Week Low
- HOWL $0.60
- ANIX $2.07
- 52 Week High
- HOWL $4.18
- ANIX $4.20
- Technical
- Relative Strength Index (RSI)
- HOWL 43.95
- ANIX 51.53
- Support Level
- HOWL $1.02
- ANIX $3.18
- Resistance Level
- HOWL $1.12
- ANIX $3.33
- Average True Range (ATR)
- HOWL 0.09
- ANIX 0.22
- MACD
- HOWL -0.03
- ANIX -0.05
- Stochastic Oscillator
- HOWL 16.67
- ANIX 12.31
About HOWL Werewolf Therapeutics Inc.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.
About ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.